Deep Track Capital, LP - Sep 12, 2025 SCHEDULE 13D Report for LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share
Shares outstanding
22.5M shares
Disclosed Ownership
3.35M shares
Ownership
14.9%
Form type
SCHEDULE 13D
Date filed
9/19/2025, 04:30 PM
Date of event
Sep 12, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Biotechnology Master Fund, Ltd. 12% 2.69M 0 2.69M /s/ David Kroin David Kroin, Director
Deep Track Special Opportunities Fund, LP 3% 667K 0 667K /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Manager
Deep Track Capital, LP 14.9% 3.35M 0 3.35M /s/ David Kroin David Kroin, Managing Member of the General Partner 0001856083
David Kroin 14.9% 3.35M 0 3.35M /s/ David Kroin David Kroin